Trial intelligence / Profile preview

Asciminib for newly diagnosed chronic phase chronic myeloid leukaemia

ACTRN12620000851965Phase 2Active, not recruiting

Sponsor

Australasian Leukaemia & Lymphoma Group

Start

Dec 2020

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

2